Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Company research

Protalix BioTherapeutics, Inc.

CIK 1006281Updated Nov 16, 2026

Name history
ORTHODONTIX INC · through Feb 22, 2007EMBASSY ACQUISITION CORP · through Mar 31, 1998

PLX price & chart

Provider market data

Loading TradingView…

AMEX:PLX on TradingView ↗

TradingView · Data may be delayed

About the company

Protalix is a biopharmaceutical company focused on the discovery, development, production, and commercialization of innovative therapeutics for rare diseases. Protalix has researched, developed, and currently manufactures two enzyme replacement therapies that are currently available in multiple markets. These therapies are recombinant therapeutic proteins expressed through Protalix’s proprietary plant cell-based expression system, ProCellEx®. ProCellEx is a unique plant cell-based system that enables Protalix to produce recombinant proteins in an industrial-scale manner with no exposure to mammalian cells. Protalix is the first company to gain U.S. Food and Drug Administration (FDA) approval of a protein produced through plant cell-based in suspension expression system. Protalix has licensed to Pfizer Inc. the worldwide development and commercialization rights to taliglucerase alfa, Elelyso®, for the treatment of Gaucher disease, excluding in Brazil where Protalix retains full rights.

8-K · 2026-11-10 · 0001104659-26-124761

Company description from the cited filing.

In the news

Seeking Alpha
SEC disclosures

Financials

FY 2025 · USD
Revenue52,744,000USD · FY 2025
Source

10-K · 2026-03-18 · 0001104659-26-029858

2025-01-01 to 2025-12-31

Net income-6,604,000USD · FY 2025
Source

10-K · 2026-03-18 · 0001104659-26-029858

2025-01-01 to 2025-12-31

Operating income-5,500,000USD · FY 2025
Source

10-K · 2026-03-18 · 0001104659-26-029858

2025-01-01 to 2025-12-31

Diluted EPS-0.08USD per share · FY 2025
Source

10-K · 2026-03-18 · 0001104659-26-029858

2025-01-01 to 2025-12-31

Some figures are unavailable for this reporting year.

balance sheet · annual statements
Line itemQ3 2025Q3 2024Q2 2026Q2 2025Q2 2024Q1 2026Q1 2025Q1 2024FY 2025FY 2024FY 2023FY 2022
ASSETS
AssetsUSD82,264,000
Source

10-Q · 2025-11-13 · 0001104659-25-110824

As of 2025-09-30

61,563,000
Source

10-Q · 2024-11-14 · 0001558370-24-015612

As of 2024-09-30

110,336,000
Source

10-Q · 2026-08-12 · 0001104659-26-094444

As of 2026-06-30

78,486,000
Source

10-Q · 2025-08-14 · 0001558370-25-011471

As of 2025-06-30

91,540,000
Source

10-Q · 2024-08-14 · 0001558370-24-012134

As of 2024-06-30

102,336,000
Source

10-Q · 2026-05-13 · 0001104659-26-059756

As of 2026-03-31

73,892,000
Source

10-Q · 2025-05-09 · 0001558370-25-007063

As of 2025-03-31

89,825,000
Source

10-Q · 2024-05-10 · 0001558370-24-007695

As of 2024-03-31

82,346,000
Source

10-K · 2026-03-18 · 0001104659-26-029858

As of 2025-12-31

73,417,000
Source

10-K · 2025-03-17 · 0001558370-25-003039

As of 2024-12-31

84,434,000
Source

10-K · 2024-03-14 · 0001558370-24-003161

As of 2023-12-31

55,787,000
Source

10-K · 2023-02-27 · 0001558370-23-002102

As of 2022-12-31

Property, Plant and Equipment, NetUSD4,724,000
Source

10-Q · 2025-11-13 · 0001104659-25-110824

As of 2025-09-30

4,648,000
Source

10-Q · 2024-11-14 · 0001558370-24-015612

As of 2024-09-30

5,467,000
Source

10-Q · 2026-08-12 · 0001104659-26-094444

As of 2026-06-30

4,746,000
Source

10-Q · 2025-08-14 · 0001558370-25-011471

As of 2025-06-30

4,609,000
Source

10-Q · 2024-08-14 · 0001558370-24-012134

As of 2024-06-30

5,153,000
Source

10-Q · 2026-05-13 · 0001104659-26-059756

As of 2026-03-31

4,725,000
Source

10-Q · 2025-05-09 · 0001558370-25-007063

As of 2025-03-31

4,781,000
Source

10-Q · 2024-05-10 · 0001558370-24-007695

As of 2024-03-31

4,879,000
Source

10-K · 2026-03-18 · 0001104659-26-029858

As of 2025-12-31

4,591,000
Source

10-K · 2025-03-17 · 0001558370-25-003039

As of 2024-12-31

4,973,000
Source

10-K · 2024-03-14 · 0001558370-24-003161

As of 2023-12-31

4,553,000
Source

10-K · 2023-02-27 · 0001558370-23-002102

As of 2022-12-31

Current assets:
Cash and Cash Equivalents, at Carrying ValueUSD13,647,000
Source

10-Q · 2025-11-13 · 0001104659-25-110824

As of 2025-09-30

27,409,000
Source

10-Q · 2024-11-14 · 0001558370-24-015612

As of 2024-09-30

27,420,000
Source

10-Q · 2026-08-12 · 0001104659-26-094444

As of 2026-06-30

17,895,000
Source

10-Q · 2025-08-14 · 0001558370-25-011471

As of 2025-06-30

23,399,000
Source

10-Q · 2024-08-14 · 0001558370-24-012134

As of 2024-06-30

41,001,000
Source

10-Q · 2026-05-13 · 0001104659-26-059756

As of 2026-03-31

19,458,000
Source

10-Q · 2025-05-09 · 0001558370-25-007063

As of 2025-03-31

27,209,000
Source

10-Q · 2024-05-10 · 0001558370-24-007695

As of 2024-03-31

14,680,000
Source

10-K · 2026-03-18 · 0001104659-26-029858

As of 2025-12-31

19,760,000
Source

10-K · 2025-03-17 · 0001558370-25-003039

As of 2024-12-31

23,634,000
Source

10-K · 2024-03-14 · 0001558370-24-003161

As of 2023-12-31

17,111,000
Source

10-K · 2023-02-27 · 0001558370-23-002102

As of 2022-12-31

Accounts Receivable, after Allowance for Credit Loss, CurrentUSD14,425,000
Source

10-Q · 2025-11-13 · 0001104659-25-110824

As of 2025-09-30

2,195,000
Source

10-Q · 2024-11-14 · 0001558370-24-015612

As of 2024-09-30

16,503,000
Source

10-Q · 2026-08-12 · 0001104659-26-094444

As of 2026-06-30

9,443,000
Source

10-Q · 2025-08-14 · 0001558370-25-011471

As of 2025-06-30

10,126,000
Source

10-Q · 2024-08-14 · 0001558370-24-012134

As of 2024-06-30

2,939,000
Source

10-Q · 2026-05-13 · 0001104659-26-059756

As of 2026-03-31

4,675,000
Source

10-Q · 2025-05-09 · 0001558370-25-007063

As of 2025-03-31

3,759,000
Source

10-Q · 2024-05-10 · 0001558370-24-007695

As of 2024-03-31

8,840,000
Source

10-K · 2026-03-18 · 0001104659-26-029858

As of 2025-12-31

2,909,000
Source

10-K · 2025-03-17 · 0001558370-25-003039

As of 2024-12-31

5,272,000
Source

10-K · 2024-03-14 · 0001558370-24-003161

As of 2023-12-31

4,586,000
Source

10-K · 2023-02-27 · 0001558370-23-002102

As of 2022-12-31

Inventory, NetUSD21,255,000
Source

10-Q · 2025-11-13 · 0001104659-25-110824

As of 2025-09-30

17,199,000
Source

10-Q · 2024-11-14 · 0001558370-24-015612

As of 2024-09-30

32,292,000
Source

10-Q · 2026-08-12 · 0001104659-26-094444

As of 2026-06-30

21,131,000
Source

10-Q · 2025-08-14 · 0001558370-25-011471

As of 2025-06-30

20,719,000
Source

10-Q · 2024-08-14 · 0001558370-24-012134

As of 2024-06-30

30,474,000
Source

10-Q · 2026-05-13 · 0001104659-26-059756

As of 2026-03-31

19,506,000
Source

10-Q · 2025-05-09 · 0001558370-25-007063

As of 2025-03-31

22,346,000
Source

10-Q · 2024-05-10 · 0001558370-24-007695

As of 2024-03-31

25,729,000
Source

10-K · 2026-03-18 · 0001104659-26-029858

As of 2025-12-31

21,243,000
Source

10-K · 2025-03-17 · 0001558370-25-003039

As of 2024-12-31

19,045,000
Source

10-K · 2024-03-14 · 0001558370-24-003161

As of 2023-12-31

16,804,000
Source

10-K · 2023-02-27 · 0001558370-23-002102

As of 2022-12-31

Assets, CurrentUSD66,502,000
Source

10-Q · 2025-11-13 · 0001104659-25-110824

As of 2025-09-30

47,853,000
Source

10-Q · 2024-11-14 · 0001558370-24-015612

As of 2024-09-30

92,220,000
Source

10-Q · 2026-08-12 · 0001104659-26-094444

As of 2026-06-30

65,485,000
Source

10-Q · 2025-08-14 · 0001558370-25-011471

As of 2025-06-30

77,367,000
Source

10-Q · 2024-08-14 · 0001558370-24-012134

As of 2024-06-30

86,356,000
Source

10-Q · 2026-05-13 · 0001104659-26-059756

As of 2026-03-31

60,514,000
Source

10-Q · 2025-05-09 · 0001558370-25-007063

As of 2025-03-31

75,404,000
Source

10-Q · 2024-05-10 · 0001558370-24-007695

As of 2024-03-31

66,673,000
Source

10-K · 2026-03-18 · 0001104659-26-029858

As of 2025-12-31

60,078,000
Source

10-K · 2025-03-17 · 0001558370-25-003039

As of 2024-12-31

69,932,000
Source

10-K · 2024-03-14 · 0001558370-24-003161

As of 2023-12-31

44,880,000
Source

10-K · 2023-02-27 · 0001558370-23-002102

As of 2022-12-31

Operating Lease, Right-of-Use AssetUSD7,810,000
Source

10-Q · 2025-11-13 · 0001104659-25-110824

As of 2025-09-30

5,645,000
Source

10-Q · 2024-11-14 · 0001558370-24-015612

As of 2024-09-30

8,175,000
Source

10-Q · 2026-08-12 · 0001104659-26-094444

As of 2026-06-30

4,997,000
Source

10-Q · 2025-08-14 · 0001558370-25-011471

As of 2025-06-30

5,730,000
Source

10-Q · 2024-08-14 · 0001558370-24-012134

As of 2024-06-30

7,793,000
Source

10-Q · 2026-05-13 · 0001104659-26-059756

As of 2026-03-31

5,225,000
Source

10-Q · 2025-05-09 · 0001558370-25-007063

As of 2025-03-31

5,879,000
Source

10-Q · 2024-05-10 · 0001558370-24-007695

As of 2024-03-31

7,700,000
Source

10-K · 2026-03-18 · 0001104659-26-029858

As of 2025-12-31

5,430,000
Source

10-K · 2025-03-17 · 0001558370-25-003039

As of 2024-12-31

5,909,000
Source

10-K · 2024-03-14 · 0001558370-24-003161

As of 2023-12-31

5,087,000
Source

10-K · 2023-02-27 · 0001558370-23-002102

As of 2022-12-31

LIABILITIES AND EQUITY
LiabilitiesUSD29,356,000
Source

10-Q · 2025-11-13 · 0001104659-25-110824

As of 2025-09-30

29,126,000
Source

10-Q · 2024-11-14 · 0001558370-24-015612

As of 2024-09-30

38,932,000
Source

10-Q · 2026-08-12 · 0001104659-26-094444

As of 2026-06-30

28,583,000
Source

10-Q · 2025-08-14 · 0001558370-25-011471

As of 2025-06-30

62,959,000
Source

10-Q · 2024-08-14 · 0001558370-24-012134

As of 2024-06-30

35,107,000
Source

10-Q · 2026-05-13 · 0001104659-26-059756

As of 2026-03-31

28,684,000
Source

10-Q · 2025-05-09 · 0001558370-25-007063

As of 2025-03-31

60,039,000
Source

10-Q · 2024-05-10 · 0001558370-24-007695

As of 2024-03-31

34,116,000
Source

10-K · 2026-03-18 · 0001104659-26-029858

As of 2025-12-31

30,206,000
Source

10-K · 2025-03-17 · 0001558370-25-003039

As of 2024-12-31

50,865,000
Source

10-K · 2024-03-14 · 0001558370-24-003161

As of 2023-12-31

66,427,000
Source

10-K · 2023-02-27 · 0001558370-23-002102

As of 2022-12-31

Stockholders’ equity:
Common Stock, Value, IssuedUSD————————80,000
Source

10-K · 2026-03-18 · 0001104659-26-029858

As of 2025-12-31

76,000
Source

10-K · 2025-03-17 · 0001558370-25-003039

As of 2024-12-31

73,000
Source

10-K · 2024-03-14 · 0001558370-24-003161

As of 2023-12-31

54,000
Source

10-K · 2023-02-27 · 0001558370-23-002102

As of 2022-12-31

Retained Earnings (Accumulated Deficit)USD————————-384,997,000
Source

10-K · 2026-03-18 · 0001104659-26-029858

As of 2025-12-31

-378,393,000
Source

10-K · 2025-03-17 · 0001558370-25-003039

As of 2024-12-31

-381,549,000
Source

10-K · 2024-03-14 · 0001558370-24-003161

As of 2023-12-31

-389,861,000
Source

10-K · 2023-02-27 · 0001558370-23-002102

As of 2022-12-31

Stockholders' Equity Attributable to ParentUSD52,908,000
Source

10-Q · 2025-11-13 · 0001104659-25-110824

As of 2025-09-30

32,437,000
Source

10-Q · 2025-11-13 · 0001104659-25-110824

As of 2024-09-30

71,404,000
Source

10-Q · 2026-08-12 · 0001104659-26-094444

As of 2026-06-30

49,903,000
Source

10-Q · 2026-08-12 · 0001104659-26-094444

As of 2025-06-30

28,581,000
Source

10-Q · 2025-08-14 · 0001558370-25-011471

As of 2024-06-30

67,229,000
Source

10-Q · 2026-05-13 · 0001104659-26-059756

As of 2026-03-31

45,208,000
Source

10-Q · 2026-05-13 · 0001104659-26-059756

As of 2025-03-31

29,786,000
Source

10-Q · 2025-05-09 · 0001558370-25-007063

As of 2024-03-31

48,230,000
Source

10-K · 2026-03-18 · 0001104659-26-029858

As of 2025-12-31

43,211,000
Source

10-K · 2025-03-17 · 0001558370-25-003039

As of 2024-12-31

33,569,000
Source

10-K · 2024-03-14 · 0001558370-24-003161

As of 2023-12-31

-10,640,000
Source

10-K · 2023-02-27 · 0001558370-23-002102

As of 2022-12-31

Additional Paid in Capital, Common StockUSD————————433,147,000
Source

10-K · 2026-03-18 · 0001104659-26-029858

As of 2025-12-31

421,528,000
Source

10-K · 2025-03-17 · 0001558370-25-003039

As of 2024-12-31

415,045,000
Source

10-K · 2024-03-14 · 0001558370-24-003161

As of 2023-12-31

379,167,000
Source

10-K · 2023-02-27 · 0001558370-23-002102

As of 2022-12-31

Liabilities and EquityUSD82,264,000
Source

10-Q · 2025-11-13 · 0001104659-25-110824

As of 2025-09-30

61,563,000
Source

10-Q · 2024-11-14 · 0001558370-24-015612

As of 2024-09-30

110,336,000
Source

10-Q · 2026-08-12 · 0001104659-26-094444

As of 2026-06-30

78,486,000
Source

10-Q · 2025-08-14 · 0001558370-25-011471

As of 2025-06-30

91,540,000
Source

10-Q · 2024-08-14 · 0001558370-24-012134

As of 2024-06-30

102,336,000
Source

10-Q · 2026-05-13 · 0001104659-26-059756

As of 2026-03-31

73,892,000
Source

10-Q · 2025-05-09 · 0001558370-25-007063

As of 2025-03-31

89,825,000
Source

10-Q · 2024-05-10 · 0001558370-24-007695

As of 2024-03-31

82,346,000
Source

10-K · 2026-03-18 · 0001104659-26-029858

As of 2025-12-31

73,417,000
Source

10-K · 2025-03-17 · 0001558370-25-003039

As of 2024-12-31

84,434,000
Source

10-K · 2024-03-14 · 0001558370-24-003161

As of 2023-12-31

55,787,000
Source

10-K · 2023-02-27 · 0001558370-23-002102

As of 2022-12-31

Current liabilities:
Liabilities, CurrentUSD21,945,000
Source

10-Q · 2025-11-13 · 0001104659-25-110824

As of 2025-09-30

24,220,000
Source

10-Q · 2024-11-14 · 0001558370-24-015612

As of 2024-09-30

31,391,000
Source

10-Q · 2026-08-12 · 0001104659-26-094444

As of 2026-06-30

24,091,000
Source

10-Q · 2025-08-14 · 0001558370-25-011471

As of 2025-06-30

57,972,000
Source

10-Q · 2024-08-14 · 0001558370-24-012134

As of 2024-06-30

27,388,000
Source

10-Q · 2026-05-13 · 0001104659-26-059756

As of 2026-03-31

24,322,000
Source

10-Q · 2025-05-09 · 0001558370-25-007063

As of 2025-03-31

54,828,000
Source

10-Q · 2024-05-10 · 0001558370-24-007695

As of 2024-03-31

26,518,000
Source

10-K · 2026-03-18 · 0001104659-26-029858

As of 2025-12-31

25,621,000
Source

10-K · 2025-03-17 · 0001558370-25-003039

As of 2024-12-31

45,530,000
Source

10-K · 2024-03-14 · 0001558370-24-003161

As of 2023-12-31

32,429,000
Source

10-K · 2023-02-27 · 0001558370-23-002102

As of 2022-12-31

Operating Lease, Liability, CurrentUSD1,397,000
Source

10-Q · 2025-11-13 · 0001104659-25-110824

As of 2025-09-30

1,508,000
Source

10-Q · 2024-11-14 · 0001558370-24-015612

As of 2024-09-30

1,666,000
Source

10-Q · 2026-08-12 · 0001104659-26-094444

As of 2026-06-30

1,472,000
Source

10-Q · 2025-08-14 · 0001558370-25-011471

As of 2025-06-30

1,450,000
Source

10-Q · 2024-08-14 · 0001558370-24-012134

As of 2024-06-30

1,433,000
Source

10-Q · 2026-05-13 · 0001104659-26-059756

As of 2026-03-31

1,425,000
Source

10-Q · 2025-05-09 · 0001558370-25-007063

As of 2025-03-31

1,453,000
Source

10-Q · 2024-05-10 · 0001558370-24-007695

As of 2024-03-31

1,384,000
Source

10-K · 2026-03-18 · 0001104659-26-029858

As of 2025-12-31

1,500,000
Source

10-K · 2025-03-17 · 0001558370-25-003039

As of 2024-12-31

1,409,000
Source

10-K · 2024-03-14 · 0001558370-24-003161

As of 2023-12-31

1,118,000
Source

10-K · 2023-02-27 · 0001558370-23-002102

As of 2022-12-31

Accounts Payable, CurrentUSD—19,577,000
Source

10-Q · 2024-11-14 · 0001558370-24-015612

As of 2024-09-30

——19,343,000
Source

10-Q · 2024-08-14 · 0001558370-24-012134

As of 2024-06-30

——18,770,000
Source

10-Q · 2024-05-10 · 0001558370-24-007695

As of 2024-03-31

——19,550,000
Source

10-K · 2024-03-14 · 0001558370-24-003161

As of 2023-12-31

12,271,000
Source

10-K · 2023-02-27 · 0001558370-23-002102

As of 2022-12-31

Operating Lease, Liability, NoncurrentUSD6,780,000
Source

10-Q · 2025-11-13 · 0001104659-25-110824

As of 2025-09-30

4,176,000
Source

10-Q · 2024-11-14 · 0001558370-24-015612

As of 2024-09-30

7,541,000
Source

10-Q · 2026-08-12 · 0001104659-26-094444

As of 2026-06-30

3,877,000
Source

10-Q · 2025-08-14 · 0001558370-25-011471

As of 2025-06-30

4,282,000
Source

10-Q · 2024-08-14 · 0001558370-24-012134

As of 2024-06-30

7,048,000
Source

10-Q · 2026-05-13 · 0001104659-26-059756

As of 2026-03-31

3,811,000
Source

10-Q · 2025-05-09 · 0001558370-25-007063

As of 2025-03-31

4,499,000
Source

10-Q · 2024-05-10 · 0001558370-24-007695

As of 2024-03-31

6,937,000
Source

10-K · 2026-03-18 · 0001104659-26-029858

As of 2025-12-31

4,026,000
Source

10-K · 2025-03-17 · 0001558370-25-003039

As of 2024-12-31

4,621,000
Source

10-K · 2024-03-14 · 0001558370-24-003161

As of 2023-12-31

4,169,000
Source

10-K · 2023-02-27 · 0001558370-23-002102

As of 2022-12-31

Additional Financial Items
Accrued Liabilities, CurrentUSD8,126,000
Source

10-Q · 2025-11-13 · 0001104659-25-110824

As of 2025-09-30

8,342,000
Source

10-Q · 2024-11-14 · 0001558370-24-015612

As of 2024-09-30

9,959,000
Source

10-Q · 2026-08-12 · 0001104659-26-094444

As of 2026-06-30

7,311,000
Source

10-Q · 2025-08-14 · 0001558370-25-011471

As of 2025-06-30

9,387,000
Source

10-Q · 2024-08-14 · 0001558370-24-012134

As of 2024-06-30

9,685,000
Source

10-Q · 2026-05-13 · 0001104659-26-059756

As of 2026-03-31

9,349,000
Source

10-Q · 2025-05-09 · 0001558370-25-007063

As of 2025-03-31

8,451,000
Source

10-Q · 2024-05-10 · 0001558370-24-007695

As of 2024-03-31

9,790,000
Source

10-K · 2026-03-18 · 0001104659-26-029858

As of 2025-12-31

9,568,000
Source

10-K · 2025-03-17 · 0001558370-25-003039

As of 2024-12-31

9,009,000
Source

10-K · 2024-03-14 · 0001558370-24-003161

As of 2023-12-31

8,008,000
Source

10-K · 2023-02-27 · 0001558370-23-002102

As of 2022-12-31

Lines labelled “Derived” are calculated from reported figures.

cash flow · annual statements
Line itemQ4 2025Q4 2024Q3 2025Q3 2024Q2 2026Q2 2025Q1 2026Q1 2025FY 2025FY 2024FY 2023FY 2022
Cash flows from operating activities:
Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD——————18,317,000
Source

10-Q · 2026-05-13 · 0001104659-26-059756

2026-01-01 to 2026-03-31

-3,619,000
Source

10-Q · 2026-05-13 · 0001104659-26-059756

2025-01-01 to 2025-03-31

-6,604,000
Source

10-K · 2026-03-18 · 0001104659-26-029858

2025-01-01 to 2025-12-31

2,932,000
Source

10-K · 2025-03-17 · 0001558370-25-003039

2024-01-01 to 2024-12-31

8,312,000
Source

10-K · 2024-03-14 · 0001558370-24-003161

2023-01-01 to 2023-12-31

-14,927,000
Source

10-K · 2023-02-27 · 0001558370-23-002102

2022-01-01 to 2022-12-31

Adjustments to reconcile net income to net cash provided by operating activities:
Share-based Payment Arrangement, Noncash ExpenseUSD——————532,000
Source

10-Q · 2026-05-13 · 0001104659-26-059756

2026-01-01 to 2026-03-31

540,000
Source

10-Q · 2026-05-13 · 0001104659-26-059756

2025-01-01 to 2025-03-31

2,297,000
Source

10-K · 2026-03-18 · 0001104659-26-029858

2025-01-01 to 2025-12-31

3,253,000
Source

10-K · 2025-03-17 · 0001558370-25-003039

2024-01-01 to 2024-12-31

3,448,000
Source

10-K · 2024-03-14 · 0001558370-24-003161

2023-01-01 to 2023-12-31

2,085,000
Source

10-K · 2023-02-27 · 0001558370-23-002102

2022-01-01 to 2022-12-31

Changes in operating assets and liabilities:
Increase (Decrease) in Accounts ReceivableUSD——————-6,408,000
Source

10-Q · 2026-05-13 · 0001104659-26-059756

2026-01-01 to 2026-03-31

2,275,000
Source

10-Q · 2026-05-13 · 0001104659-26-059756

2025-01-01 to 2025-03-31

5,890,000
Source

10-K · 2026-03-18 · 0001104659-26-029858

2025-01-01 to 2025-12-31

-2,317,000
Source

10-K · 2025-03-17 · 0001558370-25-003039

2024-01-01 to 2024-12-31

428,000
Source

10-K · 2024-03-14 · 0001558370-24-003161

2023-01-01 to 2023-12-31

1,194,000
Source

10-K · 2023-02-27 · 0001558370-23-002102

2022-01-01 to 2022-12-31

Increase (Decrease) in InventoriesUSD——————4,745,000
Source

10-Q · 2026-05-13 · 0001104659-26-059756

2026-01-01 to 2026-03-31

-1,737,000
Source

10-Q · 2026-05-13 · 0001104659-26-059756

2025-01-01 to 2025-03-31

4,486,000
Source

10-K · 2026-03-18 · 0001104659-26-029858

2025-01-01 to 2025-12-31

2,198,000
Source

10-K · 2025-03-17 · 0001558370-25-003039

2024-01-01 to 2024-12-31

2,241,000
Source

10-K · 2024-03-14 · 0001558370-24-003161

2023-01-01 to 2023-12-31

-1,150,000
Source

10-K · 2023-02-27 · 0001558370-23-002102

2022-01-01 to 2022-12-31

Deferred Income Tax Expense (Benefit)USD——59,000
Source

10-Q · 2025-11-13 · 0001104659-25-110824

2025-07-01 to 2025-09-30

443,000
Source

10-Q · 2025-11-13 · 0001104659-25-110824

2024-07-01 to 2024-09-30

71,000
Source

10-Q · 2026-08-12 · 0001104659-26-094444

2026-04-01 to 2026-06-30

231,000
Source

10-Q · 2026-08-12 · 0001104659-26-094444

2025-04-01 to 2025-06-30

71,000
Source

10-Q · 2026-05-13 · 0001104659-26-059756

2026-01-01 to 2026-03-31

-113,000
Source

10-Q · 2026-05-13 · 0001104659-26-059756

2025-01-01 to 2025-03-31

340,000
Source

10-K · 2026-03-18 · 0001104659-26-029858

2025-01-01 to 2025-12-31

236,000
Source

10-K · 2025-03-17 · 0001558370-25-003039

2024-01-01 to 2024-12-31

-3,092,000
Source

10-K · 2024-03-14 · 0001558370-24-003161

2023-01-01 to 2023-12-31

—
Net Cash Provided by (Used in) Operating ActivitiesUSD——————22,025,000
Source

10-Q · 2026-05-13 · 0001104659-26-059756

2026-01-01 to 2026-03-31

-5,058,000
Source

10-Q · 2026-05-13 · 0001104659-26-059756

2025-01-01 to 2025-03-31

-11,993,000
Source

10-K · 2026-03-18 · 0001104659-26-029858

2025-01-01 to 2025-12-31

8,674,000
Source

10-K · 2025-03-17 · 0001558370-25-003039

2024-01-01 to 2024-12-31

-1,318,000
Source

10-K · 2024-03-14 · 0001558370-24-003161

2023-01-01 to 2023-12-31

-25,000,000
Source

10-K · 2023-02-27 · 0001558370-23-002102

2022-01-01 to 2022-12-31

Cash flows from investing activities:
Net Cash Provided by (Used in) Investing ActivitiesUSD——————4,223,000
Source

10-Q · 2026-05-13 · 0001104659-26-059756

2026-01-01 to 2026-03-31

-312,000
Source

10-Q · 2026-05-13 · 0001104659-26-059756

2025-01-01 to 2025-03-31

-2,366,000
Source

10-K · 2026-03-18 · 0001104659-26-029858

2025-01-01 to 2025-12-31

4,221,000
Source

10-K · 2025-03-17 · 0001558370-25-003039

2024-01-01 to 2024-12-31

-16,711,000
Source

10-K · 2024-03-14 · 0001558370-24-003161

2023-01-01 to 2023-12-31

-5,035,000
Source

10-K · 2023-02-27 · 0001558370-23-002102

2022-01-01 to 2022-12-31

Payments for (Proceeds from) Other Investing ActivitiesUSD——————7,000
Source

10-Q · 2026-05-13 · 0001104659-26-059756

2026-01-01 to 2026-03-31

6,000
Source

10-Q · 2026-05-13 · 0001104659-26-059756

2025-01-01 to 2025-03-31

26,000
Source

10-K · 2026-03-18 · 0001104659-26-029858

2025-01-01 to 2025-12-31

-80,000
Source

10-K · 2025-03-17 · 0001558370-25-003039

2024-01-01 to 2024-12-31

142,000
Source

10-K · 2024-03-14 · 0001558370-24-003161

2023-01-01 to 2023-12-31

-593,000
Source

10-K · 2023-02-27 · 0001558370-23-002102

2022-01-01 to 2022-12-31

Payments to Acquire Property, Plant, and EquipmentUSD——————761,000
Source

10-Q · 2026-05-13 · 0001104659-26-059756

2026-01-01 to 2026-03-31

306,000
Source

10-Q · 2026-05-13 · 0001104659-26-059756

2025-01-01 to 2025-03-31

1,638,000
Source

10-K · 2026-03-18 · 0001104659-26-029858

2025-01-01 to 2025-12-31

1,282,000
Source

10-K · 2025-03-17 · 0001558370-25-003039

2024-01-01 to 2024-12-31

1,149,000
Source

10-K · 2024-03-14 · 0001558370-24-003161

2023-01-01 to 2023-12-31

628,000
Source

10-K · 2023-02-27 · 0001558370-23-002102

2022-01-01 to 2022-12-31

Cash flows from financing activities:
Net Cash Provided by (Used in) Financing ActivitiesUSD——————150,000
Source

10-Q · 2026-05-13 · 0001104659-26-059756

2026-01-01 to 2026-03-31

5,076,000
Source

10-Q · 2026-05-13 · 0001104659-26-059756

2025-01-01 to 2025-03-31

9,326,000
Source

10-K · 2026-03-18 · 0001104659-26-029858

2025-01-01 to 2025-12-31

-16,794,000
Source

10-K · 2025-03-17 · 0001558370-25-003039

2024-01-01 to 2024-12-31

24,666,000
Source

10-K · 2024-03-14 · 0001558370-24-003161

2023-01-01 to 2023-12-31

8,238,000
Source

10-K · 2023-02-27 · 0001558370-23-002102

2022-01-01 to 2022-12-31

Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD——————26,321,000
Source

10-Q · 2026-05-13 · 0001104659-26-059756

2026-01-01 to 2026-03-31

-302,000
Source

10-Q · 2026-05-13 · 0001104659-26-059756

2025-01-01 to 2025-03-31

-5,080,000
Source

10-K · 2026-03-18 · 0001104659-26-029858

2025-01-01 to 2025-12-31

-3,874,000
Source

10-K · 2025-03-17 · 0001558370-25-003039

2024-01-01 to 2024-12-31

6,523,000
Source

10-K · 2024-03-14 · 0001558370-24-003161

2023-01-01 to 2023-12-31

-21,874,000
Source

10-K · 2023-02-27 · 0001558370-23-002102

2022-01-01 to 2022-12-31

Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD——13,647,000
Source

10-Q · 2025-11-13 · 0001104659-25-110824

As of 2025-09-30

27,409,000
Source

10-Q · 2025-11-13 · 0001104659-25-110824

As of 2024-09-30

27,420,000
Source

10-Q · 2026-08-12 · 0001104659-26-094444

As of 2026-06-30

17,895,000
Source

10-Q · 2026-08-12 · 0001104659-26-094444

As of 2025-06-30

41,001,000
Source

10-Q · 2026-05-13 · 0001104659-26-059756

As of 2026-03-31

19,458,000
Source

10-Q · 2026-05-13 · 0001104659-26-059756

As of 2025-03-31

14,680,000
Source

10-K · 2026-03-18 · 0001104659-26-029858

As of 2025-12-31

19,760,000
Source

10-K · 2025-03-17 · 0001558370-25-003039

As of 2024-12-31

23,634,000
Source

10-K · 2024-03-14 · 0001558370-24-003161

As of 2023-12-31

17,111,000
Source

10-K · 2023-02-27 · 0001558370-23-002102

As of 2022-12-31

Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD————————0
Source

10-K · 2026-03-18 · 0001104659-26-029858

2025-01-01 to 2025-12-31

1,532,000
Source

10-K · 2025-03-17 · 0001558370-25-003039

2024-01-01 to 2024-12-31

2,742,000
Source

10-K · 2024-03-14 · 0001558370-24-003161

2023-01-01 to 2023-12-31

2,198,000
Source

10-K · 2023-02-27 · 0001558370-23-002102

2022-01-01 to 2022-12-31

Income Taxes Paid, NetUSD——————2,500,000
Source

10-Q · 2026-05-13 · 0001104659-26-059756

2026-01-01 to 2026-03-31

—1,183,000
Source

10-K · 2026-03-18 · 0001104659-26-029858

2025-01-01 to 2025-12-31

385,000
Source

10-K · 2025-03-17 · 0001558370-25-003039

2024-01-01 to 2024-12-31

——
Additional Financial Items
Share-based Payment Arrangement, ExpenseUSD————————2,297,000
Source

10-K · 2026-03-18 · 0001104659-26-029858

2025-01-01 to 2025-12-31

3,253,000
Source

10-K · 2025-03-17 · 0001558370-25-003039

2024-01-01 to 2024-12-31

3,448,000
Source

10-K · 2024-03-14 · 0001558370-24-003161

2023-01-01 to 2023-12-31

2,085,000
Source

10-K · 2023-02-27 · 0001558370-23-002102

2022-01-01 to 2022-12-31

Amortization of Debt Issuance Costs and DiscountsUSD————————0
Source

10-K · 2026-03-18 · 0001104659-26-029858

2025-01-01 to 2025-12-31

0
Source

10-K · 2025-03-17 · 0001558370-25-003039

2024-01-01 to 2024-12-31

267,000
Source

10-K · 2024-03-14 · 0001558370-24-003161

2023-01-01 to 2023-12-31

300,000
Source

10-K · 2023-02-27 · 0001558370-23-002102

2022-01-01 to 2022-12-31

DepreciationUSD——————404,000
Source

10-Q · 2026-05-13 · 0001104659-26-059756

2026-01-01 to 2026-03-31

346,000
Source

10-Q · 2026-05-13 · 0001104659-26-059756

2025-01-01 to 2025-03-31

1,465,000
Source

10-K · 2026-03-18 · 0001104659-26-029858

2025-01-01 to 2025-12-31

1,304,000
Source

10-K · 2025-03-17 · 0001558370-25-003039

2024-01-01 to 2024-12-31

1,191,000
Source

10-K · 2024-03-14 · 0001558370-24-003161

2023-01-01 to 2023-12-31

1,086,000
Source

10-K · 2023-02-27 · 0001558370-23-002102

2022-01-01 to 2022-12-31

Foreign Currency Transaction Gain (Loss), UnrealizedUSD——————-158,000
Source

10-Q · 2026-05-13 · 0001104659-26-059756

2026-01-01 to 2026-03-31

375,000
Source

10-Q · 2026-05-13 · 0001104659-26-059756

2025-01-01 to 2025-03-31

-606,000
Source

10-K · 2026-03-18 · 0001104659-26-029858

2025-01-01 to 2025-12-31

-310,000
Source

10-K · 2025-03-17 · 0001558370-25-003039

2024-01-01 to 2024-12-31

446,000
Source

10-K · 2024-03-14 · 0001558370-24-003161

2023-01-01 to 2023-12-31

989,000
Source

10-K · 2023-02-27 · 0001558370-23-002102

2022-01-01 to 2022-12-31

Gain (Loss) on Disposition of Property Plant EquipmentUSD————————0
Source

10-K · 2026-03-18 · 0001104659-26-029858

2025-01-01 to 2025-12-31

3,000
Source

10-K · 2025-03-17 · 0001558370-25-003039

2024-01-01 to 2024-12-31

-9,000
Source

10-K · 2024-03-14 · 0001558370-24-003161

2023-01-01 to 2023-12-31

0
Source

10-K · 2023-02-27 · 0001558370-23-002102

2022-01-01 to 2022-12-31

Gain (Loss) on Extinguishment of DebtUSD——————————0
Source

10-K · 2024-03-14 · 0001558370-24-003161

2023-01-01 to 2023-12-31

0
Source

10-K · 2023-02-27 · 0001558370-23-002102

2022-01-01 to 2022-12-31

Income Tax Expense (Benefit)USD——-116,000
Source

10-Q · 2025-11-13 · 0001104659-25-110824

2025-07-01 to 2025-09-30

607,000
Source

10-Q · 2025-11-13 · 0001104659-25-110824

2024-07-01 to 2024-09-30

1,083,000
Source

10-Q · 2026-08-12 · 0001104659-26-094444

2026-04-01 to 2026-06-30

497,000
Source

10-Q · 2026-08-12 · 0001104659-26-094444

2025-04-01 to 2025-06-30

2,824,000
Source

10-Q · 2026-05-13 · 0001104659-26-059756

2026-01-01 to 2026-03-31

-113,000
Source

10-Q · 2026-05-13 · 0001104659-26-059756

2025-01-01 to 2025-03-31

996,000
Source

10-K · 2026-03-18 · 0001104659-26-029858

2025-01-01 to 2025-12-31

1,222,000
Source

10-K · 2025-03-17 · 0001558370-25-003039

2024-01-01 to 2024-12-31

254,000
Source

10-K · 2024-03-14 · 0001558370-24-003161

2023-01-01 to 2023-12-31

530,000
Source

10-K · 2023-02-27 · 0001558370-23-002102

2022-01-01 to 2022-12-31

Inventory Write-downUSD————————30,000
Source

10-K · 2026-03-18 · 0001104659-26-029858

2025-01-01 to 2025-12-31

90,000
Source

10-K · 2025-03-17 · 0001558370-25-003039

2024-01-01 to 2024-12-31

800,000
Source

10-K · 2024-03-14 · 0001558370-24-003161

2023-01-01 to 2023-12-31

40,000
Source

10-K · 2023-02-27 · 0001558370-23-002102

2022-01-01 to 2022-12-31

Net Income (Loss) Attributable to ParentUSD——2,355,000
Source

10-Q · 2025-11-13 · 0001104659-25-110824

2025-07-01 to 2025-09-30

3,236,000
Source

10-Q · 2025-11-13 · 0001104659-25-110824

2024-07-01 to 2024-09-30

3,777,000
Source

10-Q · 2026-08-12 · 0001104659-26-094444

2026-04-01 to 2026-06-30

164,000
Source

10-Q · 2026-08-12 · 0001104659-26-094444

2025-04-01 to 2025-06-30

18,317,000
Source

10-Q · 2026-05-13 · 0001104659-26-059756

2026-01-01 to 2026-03-31

-3,619,000
Source

10-Q · 2026-05-13 · 0001104659-26-059756

2025-01-01 to 2025-03-31

-6,604,000
Source

10-K · 2026-03-18 · 0001104659-26-029858

2025-01-01 to 2025-12-31

2,932,000
Source

10-K · 2025-03-17 · 0001558370-25-003039

2024-01-01 to 2024-12-31

8,312,000
Source

10-K · 2024-03-14 · 0001558370-24-003161

2023-01-01 to 2023-12-31

-14,927,000
Source

10-K · 2023-02-27 · 0001558370-23-002102

2022-01-01 to 2022-12-31

Nonoperating Income (Expense)USD——108,000
Source

10-Q · 2025-11-13 · 0001104659-25-110824

2025-07-01 to 2025-09-30

-148,000
Source

10-Q · 2025-11-13 · 0001104659-25-110824

2024-07-01 to 2024-09-30

188,000
Source

10-Q · 2026-08-12 · 0001104659-26-094444

2026-04-01 to 2026-06-30

-511,000
Source

10-Q · 2026-08-12 · 0001104659-26-094444

2025-04-01 to 2025-06-30

-5,000
Source

10-Q · 2026-05-13 · 0001104659-26-059756

2026-01-01 to 2026-03-31

413,000
Source

10-Q · 2026-05-13 · 0001104659-26-059756

2025-01-01 to 2025-03-31

-108,000
Source

10-K · 2026-03-18 · 0001104659-26-029858

2025-01-01 to 2025-12-31

237,000
Source

10-K · 2025-03-17 · 0001558370-25-003039

2024-01-01 to 2024-12-31

-1,894,000
Source

10-K · 2024-03-14 · 0001558370-24-003161

2023-01-01 to 2023-12-31

-1,383,000
Source

10-K · 2023-02-27 · 0001558370-23-002102

2022-01-01 to 2022-12-31

Proceeds from Issuance of Common StockUSD———————2,861,000
Source

10-Q · 2026-05-13 · 0001104659-26-059756

2025-01-01 to 2025-03-31

6,812,000
Source

10-K · 2026-03-18 · 0001104659-26-029858

2025-01-01 to 2025-12-31

3,626,000
Source

10-K · 2025-03-17 · 0001558370-25-003039

2024-01-01 to 2024-12-31

23,954,000
Source

10-K · 2024-03-14 · 0001558370-24-003161

2023-01-01 to 2023-12-31

8,236,000
Source

10-K · 2023-02-27 · 0001558370-23-002102

2022-01-01 to 2022-12-31

Net Income (Loss) Available to Common Stockholders, Basic—————
Source

10-Q · 2026-08-12 · 0001104659-26-094444

2026-04-01 to 2026-06-30

—
Source

10-Q · 2026-08-12 · 0001104659-26-094444

2025-04-01 to 2025-06-30

——————

Lines labelled “Derived” are calculated from reported figures.

income statement · annual statements
Line itemQ4 2025Q4 2024Q3 2025Q3 2024Q2 2026Q2 2025Q1 2026Q1 2025FY 2025FY 2024FY 2023FY 2022
Total RevenueUSD——17,851,000
Source

10-Q · 2025-11-13 · 0001104659-25-110824

2025-07-01 to 2025-09-30

17,959,000
Source

10-Q · 2025-11-13 · 0001104659-25-110824

2024-07-01 to 2024-09-30

19,896,000
Source

10-Q · 2026-08-12 · 0001104659-26-094444

2026-04-01 to 2026-06-30

15,658,000
Source

10-Q · 2026-08-12 · 0001104659-26-094444

2025-04-01 to 2025-06-30

33,750,000
Source

10-Q · 2026-05-13 · 0001104659-26-059756

2026-01-01 to 2026-03-31

10,113,000
Source

10-Q · 2026-05-13 · 0001104659-26-059756

2025-01-01 to 2025-03-31

52,744,000
Source

10-K · 2026-03-18 · 0001104659-26-029858

2025-01-01 to 2025-12-31

53,399,000
Source

10-K · 2025-03-17 · 0001558370-25-003039

2024-01-01 to 2024-12-31

65,494,000
Source

10-K · 2024-03-14 · 0001558370-24-003161

2023-01-01 to 2023-12-31

47,638,000
Source

10-K · 2023-02-27 · 0001558370-23-002102

2022-01-01 to 2022-12-31

Cost of Goods and Services Sold———
Source

10-Q · 2025-11-13 · 0001104659-25-110824

2025-07-01 to 2025-09-30

—
Source

10-Q · 2025-11-13 · 0001104659-25-110824

2024-07-01 to 2024-09-30

—
Source

10-Q · 2026-08-12 · 0001104659-26-094444

2026-04-01 to 2026-06-30

—
Source

10-Q · 2026-08-12 · 0001104659-26-094444

2025-04-01 to 2025-06-30

—
Source

10-Q · 2026-05-13 · 0001104659-26-059756

2026-01-01 to 2026-03-31

—
Source

10-Q · 2026-05-13 · 0001104659-26-059756

2025-01-01 to 2025-03-31

—
Source

10-K · 2026-03-18 · 0001104659-26-029858

2025-01-01 to 2025-12-31

—
Source

10-K · 2025-03-17 · 0001558370-25-003039

2024-01-01 to 2024-12-31

—
Source

10-K · 2024-03-14 · 0001558370-24-003161

2023-01-01 to 2023-12-31

—
Source

10-K · 2023-02-27 · 0001558370-23-002102

2022-01-01 to 2022-12-31

Gross Profit (Calculated) · Derived————————————
Selling, General and Administrative ExpenseUSD——2,929,000
Source

10-Q · 2025-11-13 · 0001104659-25-110824

2025-07-01 to 2025-09-30

2,595,000
Source

10-Q · 2025-11-13 · 0001104659-25-110824

2024-07-01 to 2024-09-30

3,111,000
Source

10-Q · 2026-08-12 · 0001104659-26-094444

2026-04-01 to 2026-06-30

2,624,000
Source

10-Q · 2026-08-12 · 0001104659-26-094444

2025-04-01 to 2025-06-30

3,051,000
Source

10-Q · 2026-05-13 · 0001104659-26-059756

2026-01-01 to 2026-03-31

2,603,000
Source

10-Q · 2026-05-13 · 0001104659-26-059756

2025-01-01 to 2025-03-31

11,682,000
Source

10-K · 2026-03-18 · 0001104659-26-029858

2025-01-01 to 2025-12-31

12,193,000
Source

10-K · 2025-03-17 · 0001558370-25-003039

2024-01-01 to 2024-12-31

14,959,000
Source

10-K · 2024-03-14 · 0001558370-24-003161

2023-01-01 to 2023-12-31

11,711,000
Source

10-K · 2023-02-27 · 0001558370-23-002102

2022-01-01 to 2022-12-31

Operating Income (Loss)USD——2,131,000
Source

10-Q · 2025-11-13 · 0001104659-25-110824

2025-07-01 to 2025-09-30

3,991,000
Source

10-Q · 2025-11-13 · 0001104659-25-110824

2024-07-01 to 2024-09-30

4,672,000
Source

10-Q · 2026-08-12 · 0001104659-26-094444

2026-04-01 to 2026-06-30

1,172,000
Source

10-Q · 2026-08-12 · 0001104659-26-094444

2025-04-01 to 2025-06-30

21,146,000
Source

10-Q · 2026-05-13 · 0001104659-26-059756

2026-01-01 to 2026-03-31

-4,145,000
Source

10-Q · 2026-05-13 · 0001104659-26-059756

2025-01-01 to 2025-03-31

-5,500,000
Source

10-K · 2026-03-18 · 0001104659-26-029858

2025-01-01 to 2025-12-31

3,917,000
Source

10-K · 2025-03-17 · 0001558370-25-003039

2024-01-01 to 2024-12-31

10,460,000
Source

10-K · 2024-03-14 · 0001558370-24-003161

2023-01-01 to 2023-12-31

-13,014,000
Source

10-K · 2023-02-27 · 0001558370-23-002102

2022-01-01 to 2022-12-31

Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD——2,239,000
Source

10-Q · 2025-11-13 · 0001104659-25-110824

2025-07-01 to 2025-09-30

3,843,000
Source

10-Q · 2025-11-13 · 0001104659-25-110824

2024-07-01 to 2024-09-30

4,860,000
Source

10-Q · 2026-08-12 · 0001104659-26-094444

2026-04-01 to 2026-06-30

661,000
Source

10-Q · 2026-08-12 · 0001104659-26-094444

2025-04-01 to 2025-06-30

21,141,000
Source

10-Q · 2026-05-13 · 0001104659-26-059756

2026-01-01 to 2026-03-31

-3,732,000
Source

10-Q · 2026-05-13 · 0001104659-26-059756

2025-01-01 to 2025-03-31

-5,608,000
Source

10-K · 2026-03-18 · 0001104659-26-029858

2025-01-01 to 2025-12-31

4,154,000
Source

10-K · 2025-03-17 · 0001558370-25-003039

2024-01-01 to 2024-12-31

8,566,000
Source

10-K · 2024-03-14 · 0001558370-24-003161

2023-01-01 to 2023-12-31

-14,397,000
Source

10-K · 2023-02-27 · 0001558370-23-002102

2022-01-01 to 2022-12-31

Income Tax Expense (Benefit)USD——-116,000
Source

10-Q · 2025-11-13 · 0001104659-25-110824

2025-07-01 to 2025-09-30

607,000
Source

10-Q · 2025-11-13 · 0001104659-25-110824

2024-07-01 to 2024-09-30

1,083,000
Source

10-Q · 2026-08-12 · 0001104659-26-094444

2026-04-01 to 2026-06-30

497,000
Source

10-Q · 2026-08-12 · 0001104659-26-094444

2025-04-01 to 2025-06-30

2,824,000
Source

10-Q · 2026-05-13 · 0001104659-26-059756

2026-01-01 to 2026-03-31

-113,000
Source

10-Q · 2026-05-13 · 0001104659-26-059756

2025-01-01 to 2025-03-31

996,000
Source

10-K · 2026-03-18 · 0001104659-26-029858

2025-01-01 to 2025-12-31

1,222,000
Source

10-K · 2025-03-17 · 0001558370-25-003039

2024-01-01 to 2024-12-31

254,000
Source

10-K · 2024-03-14 · 0001558370-24-003161

2023-01-01 to 2023-12-31

530,000
Source

10-K · 2023-02-27 · 0001558370-23-002102

2022-01-01 to 2022-12-31

Net Income (Loss) Attributable to ParentUSD——2,355,000
Source

10-Q · 2025-11-13 · 0001104659-25-110824

2025-07-01 to 2025-09-30

3,236,000
Source

10-Q · 2025-11-13 · 0001104659-25-110824

2024-07-01 to 2024-09-30

3,777,000
Source

10-Q · 2026-08-12 · 0001104659-26-094444

2026-04-01 to 2026-06-30

164,000
Source

10-Q · 2026-08-12 · 0001104659-26-094444

2025-04-01 to 2025-06-30

18,317,000
Source

10-Q · 2026-05-13 · 0001104659-26-059756

2026-01-01 to 2026-03-31

-3,619,000
Source

10-Q · 2026-05-13 · 0001104659-26-059756

2025-01-01 to 2025-03-31

-6,604,000
Source

10-K · 2026-03-18 · 0001104659-26-029858

2025-01-01 to 2025-12-31

2,932,000
Source

10-K · 2025-03-17 · 0001558370-25-003039

2024-01-01 to 2024-12-31

8,312,000
Source

10-K · 2024-03-14 · 0001558370-24-003161

2023-01-01 to 2023-12-31

-14,927,000
Source

10-K · 2023-02-27 · 0001558370-23-002102

2022-01-01 to 2022-12-31

Earnings Per Share, BasicUSD per share——0.03
Source

10-Q · 2025-11-13 · 0001104659-25-110824

2025-07-01 to 2025-09-30

0.04
Source

10-Q · 2025-11-13 · 0001104659-25-110824

2024-07-01 to 2024-09-30

0.05
Source

10-Q · 2026-08-12 · 0001104659-26-094444

2026-04-01 to 2026-06-30

0
Source

10-Q · 2026-08-12 · 0001104659-26-094444

2025-04-01 to 2025-06-30

0.23
Source

10-Q · 2026-05-13 · 0001104659-26-059756

2026-01-01 to 2026-03-31

-0.05
Source

10-Q · 2026-05-13 · 0001104659-26-059756

2025-01-01 to 2025-03-31

-0.08
Source

10-K · 2026-03-18 · 0001104659-26-029858

2025-01-01 to 2025-12-31

0.04
Source

10-K · 2025-03-17 · 0001558370-25-003039

2024-01-01 to 2024-12-31

0.12
Source

10-K · 2024-03-14 · 0001558370-24-003161

2023-01-01 to 2023-12-31

-0.31
Source

10-K · 2023-02-27 · 0001558370-23-002102

2022-01-01 to 2022-12-31

Earnings Per Share, DilutedUSD per share——0.03
Source

10-Q · 2025-11-13 · 0001104659-25-110824

2025-07-01 to 2025-09-30

0.03
Source

10-Q · 2025-11-13 · 0001104659-25-110824

2024-07-01 to 2024-09-30

0.05
Source

10-Q · 2026-08-12 · 0001104659-26-094444

2026-04-01 to 2026-06-30

0
Source

10-Q · 2026-08-12 · 0001104659-26-094444

2025-04-01 to 2025-06-30

0.22
Source

10-Q · 2026-05-13 · 0001104659-26-059756

2026-01-01 to 2026-03-31

-0.05
Source

10-Q · 2026-05-13 · 0001104659-26-059756

2025-01-01 to 2025-03-31

-0.08
Source

10-K · 2026-03-18 · 0001104659-26-029858

2025-01-01 to 2025-12-31

0.04
Source

10-K · 2025-03-17 · 0001558370-25-003039

2024-01-01 to 2024-12-31

0.09
Source

10-K · 2024-03-14 · 0001558370-24-003161

2023-01-01 to 2023-12-31

-0.31
Source

10-K · 2023-02-27 · 0001558370-23-002102

2022-01-01 to 2022-12-31

Weighted Average Number of Shares Outstanding, Basicshares——79,281,685
Source

10-Q · 2025-11-13 · 0001104659-25-110824

2025-07-01 to 2025-09-30

73,549,745
Source

10-Q · 2025-11-13 · 0001104659-25-110824

2024-07-01 to 2024-09-30

79,986,325
Source

10-Q · 2026-08-12 · 0001104659-26-094444

2026-04-01 to 2026-06-30

78,663,884
Source

10-Q · 2026-08-12 · 0001104659-26-094444

2025-04-01 to 2025-06-30

79,848,892
Source

10-Q · 2026-05-13 · 0001104659-26-059756

2026-01-01 to 2026-03-31

76,611,980
Source

10-Q · 2026-05-13 · 0001104659-26-059756

2025-01-01 to 2025-03-31

78,546,234
Source

10-K · 2026-03-18 · 0001104659-26-029858

2025-01-01 to 2025-12-31

72,530,698
Source

10-K · 2025-03-17 · 0001558370-25-003039

2024-01-01 to 2024-12-31

67,512,527
Source

10-K · 2024-03-14 · 0001558370-24-003161

2023-01-01 to 2023-12-31

48,472,159
Source

10-K · 2023-02-27 · 0001558370-23-002102

2022-01-01 to 2022-12-31

Weighted Average Number of Shares Outstanding, Dilutedshares——80,814,564
Source

10-Q · 2025-11-13 · 0001104659-25-110824

2025-07-01 to 2025-09-30

81,217,068
Source

10-Q · 2025-11-13 · 0001104659-25-110824

2024-07-01 to 2024-09-30

82,560,235
Source

10-Q · 2026-08-12 · 0001104659-26-094444

2026-04-01 to 2026-06-30

81,271,610
Source

10-Q · 2026-08-12 · 0001104659-26-094444

2025-04-01 to 2025-06-30

83,048,596
Source

10-Q · 2026-05-13 · 0001104659-26-059756

2026-01-01 to 2026-03-31

76,611,980
Source

10-Q · 2026-05-13 · 0001104659-26-059756

2025-01-01 to 2025-03-31

78,546,234
Source

10-K · 2026-03-18 · 0001104659-26-029858

2025-01-01 to 2025-12-31

81,057,176
Source

10-K · 2025-03-17 · 0001558370-25-003039

2024-01-01 to 2024-12-31

82,424,016
Source

10-K · 2024-03-14 · 0001558370-24-003161

2023-01-01 to 2023-12-31

48,472,159
Source

10-K · 2023-02-27 · 0001558370-23-002102

2022-01-01 to 2022-12-31

Additional Financial Items
Current Income Tax Expense (Benefit)USD——-175,000
Source

10-Q · 2025-11-13 · 0001104659-25-110824

2025-07-01 to 2025-09-30

164,000
Source

10-Q · 2025-11-13 · 0001104659-25-110824

2024-07-01 to 2024-09-30

1,012,000
Source

10-Q · 2026-08-12 · 0001104659-26-094444

2026-04-01 to 2026-06-30

266,000
Source

10-Q · 2026-08-12 · 0001104659-26-094444

2025-04-01 to 2025-06-30

2,753,000
Source

10-Q · 2026-05-13 · 0001104659-26-059756

2026-01-01 to 2026-03-31

—656,000
Source

10-K · 2026-03-18 · 0001104659-26-029858

2025-01-01 to 2025-12-31

986,000
Source

10-K · 2025-03-17 · 0001558370-25-003039

2024-01-01 to 2024-12-31

3,346,000
Source

10-K · 2024-03-14 · 0001558370-24-003161

2023-01-01 to 2023-12-31

—
Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD————————-4,579,000
Source

10-K · 2026-03-18 · 0001104659-26-029858

2025-01-01 to 2025-12-31

———
Labor and Related ExpenseUSD———————5,205,000
Source

10-Q · 2025-05-09 · 0001558370-25-007063

2025-01-01 to 2025-03-31

—21,780,000
Source

10-K · 2025-03-17 · 0001558370-25-003039

2024-01-01 to 2024-12-31

——
Nonoperating Income (Expense)USD——108,000
Source

10-Q · 2025-11-13 · 0001104659-25-110824

2025-07-01 to 2025-09-30

-148,000
Source

10-Q · 2025-11-13 · 0001104659-25-110824

2024-07-01 to 2024-09-30

188,000
Source

10-Q · 2026-08-12 · 0001104659-26-094444

2026-04-01 to 2026-06-30

-511,000
Source

10-Q · 2026-08-12 · 0001104659-26-094444

2025-04-01 to 2025-06-30

-5,000
Source

10-Q · 2026-05-13 · 0001104659-26-059756

2026-01-01 to 2026-03-31

413,000
Source

10-Q · 2026-05-13 · 0001104659-26-059756

2025-01-01 to 2025-03-31

-108,000
Source

10-K · 2026-03-18 · 0001104659-26-029858

2025-01-01 to 2025-12-31

237,000
Source

10-K · 2025-03-17 · 0001558370-25-003039

2024-01-01 to 2024-12-31

-1,894,000
Source

10-K · 2024-03-14 · 0001558370-24-003161

2023-01-01 to 2023-12-31

-1,383,000
Source

10-K · 2023-02-27 · 0001558370-23-002102

2022-01-01 to 2022-12-31

Research and Development ExpenseUSD——4,467,000
Source

10-Q · 2025-11-13 · 0001104659-25-110824

2025-07-01 to 2025-09-30

2,998,000
Source

10-Q · 2025-11-13 · 0001104659-25-110824

2024-07-01 to 2024-09-30

4,351,000
Source

10-Q · 2026-08-12 · 0001104659-26-094444

2026-04-01 to 2026-06-30

5,992,000
Source

10-Q · 2026-08-12 · 0001104659-26-094444

2025-04-01 to 2025-06-30

5,426,000
Source

10-Q · 2026-05-13 · 0001104659-26-059756

2026-01-01 to 2026-03-31

3,475,000
Source

10-Q · 2026-05-13 · 0001104659-26-059756

2025-01-01 to 2025-03-31

19,569,000
Source

10-K · 2026-03-18 · 0001104659-26-029858

2025-01-01 to 2025-12-31

12,970,000
Source

10-K · 2025-03-17 · 0001558370-25-003039

2024-01-01 to 2024-12-31

17,093,000
Source

10-K · 2024-03-14 · 0001558370-24-003161

2023-01-01 to 2023-12-31

29,349,000
Source

10-K · 2023-02-27 · 0001558370-23-002102

2022-01-01 to 2022-12-31

Net Income (Loss) Available to Common Stockholders, Basic—————
Source

10-Q · 2026-08-12 · 0001104659-26-094444

2026-04-01 to 2026-06-30

—
Source

10-Q · 2026-08-12 · 0001104659-26-094444

2025-04-01 to 2025-06-30

——————

Lines labelled “Derived” are calculated from reported figures.

Filing attachments

plx-ex99d1.htm · 8-K · 2026-11-10

Exhibit 99.1 ‌ Protalix BioTherapeutics Reports Third Quarter 2026 Financial and Business Results Company to host conference call and webcast today at 8:00 a.m. ET Total revenues increased by $32.0 million year to date to $75.6 million, from $43.6 million for the same period in 2025 Net income was $4.0 million for the third quarter, up from $2.4 million in the third quarter of 2025, and net income was $26.1 million for the nine months ended September 30, 2026 Management expects to me…

8-K · 2026-11-10 · 0001104659-26-124761

Read attachment ↗
plx-20260812xex99d1.htm · 8-K · 2026-08-12

EX-99.1 2 plx-20260812xex99d1.htm EX-99.1 Exhibit 99.1 Protalix BioTherapeutics Reports Second Quarter 2026 Financial and Business Results Company to host conference call and webcast today at 8:00 a.m. EDT Revenues from selling goods increased to $19.8 million in the second quarter of 2026, up $4.4 million from the second quarter of 2025, driven primarily by sales of Elfabrio® Total revenue climbed to $53.6 million, year to date, from $25.8 million for the same period in 2025, whic…

8-K · 2026-08-12 · 0001104659-26-094433

Read attachment ↗
plx-20260521xex99d1.htm · 8-K · 2026-05-21

EX-99.1 2 plx-20260521xex99d1.htm EX-99.1 Exhibit 99.1 1 PROTALIX BIOTHERAPEUTICS C O R P O R A T E P R E S E N T A T I O N J u n e 2024 PROTALIX BIOTHERAPEUTICS Pioneering solutions to transform the treatment of rare diseases C O R P O R A T E P R E S E N T A T I O N M a y 2026 2 Forward-Looking Statements This presentation contains forward-looking statements that involve risks and uncertainties within the meaning of Section 27A of the Securities Act of 1933, as am…

8-K · 2026-05-21 · 0001104659-26-064850

Read attachment ↗
plx-20260513xex99d1.htm · 8-K · 2026-05-13

EX-99.1 2 plx-20260513xex99d1.htm EX-99.1 Exhibit 99.1 Protalix BioTherapeutics Reports First Quarter 2026 Financial and Business Results Company to host conference call and webcast today at 8:00 a.m. EDT Elfabrio commercial execution continues following European Commission approval of the 2 mg/kg every-4-weeks (E4W) dosing regimen; $25 million milestone received from Chiesi PRX-115 Phase 2 study continues to advance as planned with top-line results anticipated in the second half o…

8-K · 2026-05-13 · 0001104659-26-059749

Read attachment ↗
plx-20251231xex4d4.htm · 10-K · 2026-03-18

EXHIBIT 4.4 DESCRIPTION OF CAPITAL STOCK The following summarizes the material terms of the capital stock of Protalix BioTherapeutics, Inc. We are a Delaware corporation. The rights of our stockholders are governed by the Delaware General Corporation Law (the “DGCL”) and by our Certificate of Incorporation, as amended (the “Charter”), and our Second Amended and Restated Bylaws (the “Bylaws”), which are exhibits to our Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commi…

10-K · 2026-03-18 · 0001104659-26-029858

Read attachment ↗
plx-20260318xex99d1.htm · 8-K · 2026-03-18

EX-99.1 2 plx-20260318xex99d1.htm EX-99.1 Exhibit 99.1 Protalix BioTherapeutics Reports Fiscal Year 2025 Financial and Business Results Company to host conference call and webcast today at 8:00 a.m. EDT The European Commission (EC) approved the 2mg/kg every-4-weeks (E4W) dosing regimen for Elfabrio® in adults living with Fabry disease providing a meaningful reduction in treatment burden without compromising efficacy The EC approval triggered the Company’s entitlement to a $25.0 mil…

8-K · 2026-03-18 · 0001104659-26-029846

Read attachment ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.